COVID-19: Waseda Univ., Ultrasensitive Antigen Test: Virus detection in 30 minutes

COVID-19: Waseda Univ., Ultrasensitive Antigen Test: Virus detection in 30 minutes

COVID-19:

Waseda University: Professor Ito. Research group

Significantly simplifies the conventional PCR test method,
High virus detection sensitivity,
We have succeeded in developing an ultrasensitive antigen test method (new test method).

A quick and easy “antigen test”:

For new coronavirus infectious diseases, PCR tests are difficult to perform in general clinics.

There is a long-awaited demand for the spread of “antigen tests” that can replace these methods and can be tested quickly and easily.

Conventional problems:

Until now, antigen tests had problems such as “insufficient detection sensitivity and inability to distinguish detected viruses”.

This solution:

Use the microplate reader provided in many laboratories.

We have developed a cheaper and simpler method than the PCR test, which only measures the change in absorption of light of a specific wavelength.

In the future, we will carry out measurements on actual patient samples as soon as possible and aim to detect viruses in 30 minutes.

Utilize a microplate reader

“The ultra-sensitive quantitative measurement method of ultra-trace amount protein that we have been working on” was applied.

Using a microplate reader, you can “detect a virus simply by measuring the change in absorption of light of a specific wavelength”.

The reagents used are much cheaper than PCR tests and can detect new coronavirus with high sensitivity.

Results of this research:

It was published in the international scientific magazine “Diagnostics” on August 14, 2020 (Japan time).

https://www.jst.go.jp/pr/announce/20200819/index.html

Received: 17 July 2020; Accepted: 12 August 2020; Published: 14 August 2020

Abstract:

Polymerase chain reaction (PCR)-based antigen tests are technically difficult,

time-consuming, and expensive, and may produce false negative results requiring follow-up confirmation with computed tomography.

The global coronavirus disease 2019 (COVID-19) pandemic

has increased the demand for accurate, easy-to-use, rapid, and cost-effective antigen tests for clinical application.

We propose a de novo antigen test for diagnosing COVID-19 using the combination of sandwich enzyme-linked immunosorbent assay and thio-nicotinamide adenine dinucleotide (thio-NAD) cycling.

Our test

takes advantage of the spike proteins specific to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus.

The limit of detection of our test was 2.3 × 10−18 moles/assay.

If the virus has ~25 spike proteins on its surface, our method should detect on the order of 10−20 moles of virus/assay, corresponding to ~104 copies of the virus RNA/assay.

The detection sensitivity

approaches that of PCR-based assays because the average virus RNA load used for PCR-based assays is ~105 copies per oro- or naso-pharyngeal swab specimen.

To our knowledge, this is the first ultrasensitive antigen test for SARS-CoV-2 spike proteins that can be performed with an easy-to-use microplate reader.

Sufficient sensitivity can be achieved within 10 min of thio-NAD cycling.

Our antigen test allows for rapid, cost-effective, specific, ultrasensitive, and simultaneous multiple measurements of SARS-CoV-2, and has broad application for the diagnosis for COVID-19.

https://res.mdpi.com/d_attachment/diagnostics/diagnostics-10-00594/article_deploy/diagnostics-10-00594.pdf